Eqis Capital Management, Inc. Novartis Ag Transaction History
Eqis Capital Management, Inc.
- $1.21 Billion
- Q3 2024
A detailed history of Eqis Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 7,116 shares of NVS stock, worth $699,858. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,116
Previous 8,671
17.93%
Holding current value
$699,858
Previous $923,000
11.38%
% of portfolio
0.07%
Previous 0.08%
Shares
27 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.2 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.18 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$796 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$687 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$567 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $212B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...